Stephen J. Aselage
2009
In 2009, Stephen J. Aselage earned a total compensation of $1.4M as Executive Vice President & Chief Business Officer at BioMarin Pharmaceutical, a 43% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $155,459 |
|---|---|
| Option Awards | $683,100 |
| Salary | $361,525 |
| Stock Awards | $172,680 |
| Other | $13,685 |
| Total | $1,386,449 |
Aselage received $683.1K in option awards, accounting for 49% of the total pay in 2009.
Aselage also received $155.5K in non-equity incentive plan, $361.5K in salary, $172.7K in stock awards and $13.7K in other compensation.
Rankings
In 2009, Stephen J. Aselage's compensation ranked 3,430th out of 9,885 executives tracked by ExecPay. In other words, Aselage earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,430 out of 9,885 | 65th |
Division Manufacturing | 1,198 out of 3,690 | 68th |
Major group Chemicals And Allied Products | 233 out of 871 | 73rd |
Industry group Drugs | 134 out of 643 | 79th |
Industry Pharmaceutical Preparations | 109 out of 446 | 76th |
Source: SEC filing on March 23, 2012.
Aselage's colleagues
We found four more compensation records of executives who worked with Stephen J. Aselage at BioMarin Pharmaceutical in 2009.